DOAC's (Direct Oral Anticoagulants) can interfere in several blood coagulation assays. DOAC Remove is used for the exclusion of interferences in TT, aPTT, Lupus Anticoagulans, APC Resistance due to Direct Oral Anticoagulant (DOAC) compounds in plasma samples. DOAC removes Dabigatran, Rivaroxaban, Apixaban, Edoxaban or Argatroban from human citrated plasma. DOAC-Remove has no significant effect on acitivities of coagulation factors. Characteristics •Reliable results in blood coagulation tests which can be trusted •Easy, short handling: Incubation with 0.5 -2.0 mL plasma and centrifugation •Centrifuged plasmas can be used immediately or frozen •Long shelf life •Removes all different DOAC's available Also available for the removal of DOACs from plasma: •DOAC Remove 250, Art.No. 5D-82410-C, 250 Tests •DP Filter, Art.No. 5D-82412, Columns for removal of DOACs Available for the in vitro removal of Heparins from plasma: •HEPA-Remove, Art.No. 5D-68179, Heparin Blocker for the in vitro use in the lab only
Please see our Privacy Policy